ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Channel Therapeutics Corporation

Channel Therapeutics Corporation (CHRO)

0.6458
0.0146
( 2.31% )
Updated: 13:01:24

Channel Therapeutics Corporation Financial Summary

The current CHRO market cap is 3.89M. The company's latest EPS is USD -1.2245 and P/E is -0.50.

Quarter End Mar 2024Jun 2024
USD ($)USD ($)
Total Revenue 00
Operating Income -1.93M-1.76M
Net Income -2.56M-1.77M
Year End December 30 2023 20222023
USD ($)USD ($)
Total Revenue 00
Operating Income -2.32M-6.86M
Net Income -2.46M-7.38M
Quarter End Mar 2024Jun 2024
USD ($)USD ($)
Total Assets 4.03M2.6M
Total Liabilities 2.9M2.79M
Total Equity 1.13M-183k
Year End December 30 2023 20222023
USD ($)USD ($)
Total Assets 55k96k
Total Liabilities 3.76M6.54M
Total Equity -3.71M-6.45M
Quarter End Mar 2024Jun 2024
USD ($)USD ($)
Operating -1.99M-4.94M
Investing N/A N/A
Financing 5.67M7.25M
Year End December 30 2023 20222023
USD ($)USD ($)
Operating -1.57M-981k
Investing N/A N/A
Financing 1.62M1.02M
Market Cap 3.89M
Price to Earnings Ratio -0.50
Price to Sales Ratio 0
Price to Cash Ratio 38.36
Price to Book Ratio -0.57
Dividend Yield -

Share Statistics

Shares Outstanding 6.03M
Average Volume (1 week) 95.86k
Average Volume (1 Month) 176.68k
52 Week Change -89.24%
52 Week High 6.00
52 Week Low 0.45
Spread (Intraday) 0.03 (4%)

Company Info

Company Name Channel Therapeutics Corporation
Address 50 west liberty street
reno, nevada 89501
Website https://channeltherapeutics.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock